OPEN ENROLLMENT
Pilot Study of Add-On Fycompa (perampanel) Treatment for Catamenial Epilepsy
The procedures of this study include clinical measurements to assess seizure frequency, a questionnaire to determine the risk of hurting yourself, as well as the collection of blood and urine for a…
- Investigator
- Katherine Zarroli
- IRB Number
- IRB202102694
- Location
- Jacksonville
OPEN ENROLLMENT
Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures
Study EP0162 is a double-blind, randomized, placebo-controlled, multi-center, parallel-group, Phase 3 study to investigate the efficacy and safety of Staccato alprazolam in an outpatient setting in…
- Investigator
- Ramon Bautista, Suparna Krishnaiengar, Katherine Zarroli
- IRB Number
- WIRB20216831
- Ages
- 12 Years
- Sexes
- All
- Location
- Jacksonville
OPEN ENROLLMENT
Safety and Therapeutic Measures of Transcranial Cathodal Direct Current Stimulation (tDCS) in Patients with Refractory Focal Epilepsy
The purpose of this research is to learn more about Transcranial Cathodal Direct Current Stimulation (tDCS) and to see if it can help reduce the frequency of seizures in both…
- Investigator
- Ramon Bautista, Suparna Krishnaiengar, Katherine Zarroli
- IRB Number
- WIRB20212642
- Location
- Jacksonville
OPEN ENROLLMENT
The SMILE 3 Initiative: Improving the well-being of persons with epilepsy
The purpose of this study is to see whether incorporating services that help patients with epilepsy learn about stress management will improve their overall well-being….
- Investigator
- Ramon Bautista
- IRB Number
- IRB202200383
- Ages
- 18 Years – 88 Years
- Sexes
- All
- Location
- Jacksonville
An Outpatient Physical Therapy and Golf Program Designed for Individuals with Movement Disorders
The importance of physical activity for individuals with movement disorders, including Parkinson disease and Essential tremor, has been established. Barriers including patient engagement continue to…
- Investigator
- Michael Pulley
- IRB Number
- IRB202202232
- Location
- Jacksonville
Radicava (Edaravone) Biomarker Study
Radicava (Edaravone) Biomarker Study in Participants with Amyotrophic Lateral Sclerosis Optional DNA Sample…
- Investigator
- Katherine Zarroli
- IRB Number
- CED000000235
- Location
- Jacksonville
A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of carisbamate (ykp509) as adjunctive treatment forseizures associated with lennox-gastaut syndrome in children and adults, with optional open-label extension (20225661)
A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of carisbamate (ykp509) as adjunctive treatment forseizures associated with lennox-gastaut syndrome in…
- Investigator
- Ramon Bautista
- IRB Number
- IRB202102694
- Location
- Jacksonville
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Tolerability, Safety, and Efficacy of PRAX-944 in the Treatment of Adults with Essential Tremor (20214448)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Tolerability, Safety, and Efficacy of PRAX-944 in the Treatment of Adults with Essential…
- Investigator
- Joseph Legacy
- IRB Number
- 1329062
- Location
- Jacksonville
A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (20202174)
A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (20202174)…
- Investigator
- Michael Pulley
- IRB Number
- 1289306
- Location
- Jacksonville
Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies (20193186)
Long-Term, Observational, Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies (20193186)…
- Investigator
- Michael Pulley
- IRB Number
- 1295785
- Location
- Jacksonville
Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (20203748)
Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating…
- Investigator
- Michael Pulley
- IRB Number
- 1299632
- Location
- Jacksonville
A phase 3, multi-center, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of reldesemtiv in patients with amyotrophic lateral sclerosis (als) (20211633)
A phase 3, multi-center, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of reldesemtiv in patients with amyotrophic lateral sclerosis (als) (20211633)…
- Investigator
- Michael Pulley
- IRB Number
- 1313008
- Location
- Jacksonville
A phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab in patients with generalized myasthenia gravis (20210645)
A phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab in patients with generalized…
- Investigator
- Michael Pulley
- IRB Number
- 1320377
- Location
- Jacksonville
A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031) (20225090)
A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031) (20225090)…
- Investigator
- Michael Pulley
- IRB Number
- 1342397
- Location
- Jacksonville
A multicenter, randomized, double-blind, parallel-group, placebo-controlled variable treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in patients with secondary progressive multiple sclerosis (20130508)
A multicenter, randomized, double-blind, parallel-group, placebo-controlled variable treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in patients with secondary…
- Investigator
- Scott Silliman
- IRB Number
- 1141678
- Location
- Jacksonville
A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera™ (Dimethyl Fumarate)
When Used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM) (20131917)…
- Investigator
- Scott Silliman
- IRB Number
- 1155339
- Location
- Jacksonville
Safety and therapeutic measures of transcranial cathodal direct current stimulation (tdcs) in patients with refractory focal epilepsy (20212642)
Safety and therapeutic measures of transcranial cathodal direct current stimulation (tdcs) in patients with refractory focal epilepsy (20212642)…
- Investigator
- Katherine Zarroli
- IRB Number
- 1332866
- Location
- Jacksonville
A double-blind, randomized, placebo-controlled, multicenter, outpatient, parallel-group study to assess the efficacy and safety of staccato alprazolam in study participants 12 years of age and older with stereotypical prolonged seizures (20216831)
A double-blind, randomized, placebo-controlled, multicenter, outpatient, parallel-group study to assess the efficacy and safety of staccato alprazolam in study participants 12 years of age and older…
- Investigator
- Suparna Krishnaiengar
- IRB Number
- 1324323
- Location
- Jacksonville
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of staccato alprazolam in study participants 12 years of age and older with stereotypical prolonged seizures (20216843)
An open-label, multicenter, outpatient extension study to evaluate the safety and tolerability of staccato alprazolam in study participants 12 years of age and older with stereotypical prolonged…
- Investigator
- Suparna Krishnaiengar
- IRB Number
- 1324368
- Location
- Jacksonville